Intellia Therapeutics
Price & Volume
Stats
See moreOpen | $10.89 |
Previous Close | $10.74 |
Day Range | $10.73-$11.13 |
52W Range | $5.90-$24.16 |
Market Cap | $1.1B |
Shares Short | 28M |
Financials
See moreRevenue (12 Mos) | $52.8M |
Revenue Growth (YoY) | 104.8% |
Gross Profit (12 Mos) | -$387.2M |
Diluted EPS | -$4.69 |
News
See moreYahoo Finance • 5 days ago
Intellia Therapeutics Inc (NASDAQ:NTLA) Q2 2025 Earnings: Revenue Surpasses Estimates, Losses Narrower Than Expected
Yahoo Finance • 6 days ago
Intellia Therapeutics Q2 2025 Earnings Preview
Yahoo Finance • 13 days ago
Intellia Therapeutics to Hold Conference Call to Discuss Second Quarter 2025 Earnings and Company Updates
Yahoo Finance • last month
The Next Moderna? This Clinical-Stage Biotech Has Breakout Potential.
About
CEO | Dr. John M. Leonard M.D. |
Address | 40 Erie Street, Cambridge, MA, United States, 02139 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 403 |
